BCYC Q2 2023 Earnings — Bicycle Therapeutics plc Revenue & Financial Results | Market Cap Arena

BCYCBicycle Therapeutics plc

$374M

Q2 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$11M+160.3% YoY

Gross Profit

$11M100.0% margin

Operating Income

-$43M-378.3% margin

Net Income

-$43M-373.8% margin

EPS (Diluted)

$-1.41

QoQ Revenue Growth

+132.8%

Cash Flow

Operating Cash Flow

$34M

Free Cash Flow

$34M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$454M

Total Liabilities

$234M

Stockholders' Equity

$220M

Cash & Equivalents

$340M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$11M	$4M	+160.3%
Gross Profit	$11M	$4M	+160.3%
Operating Income	-$43M	-$27M	-57.9%
Net Income	-$43M	-$27M	-58.8%